233 related articles for article (PubMed ID: 25130828)
21. Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis.
Robin M; de Wreede LC; Padron E; Bakunina K; Fenaux P; Koster L; Nazha A; Beelen DW; Rampal RK; Sockel K; Komrokji RS; Gagelmann N; Eikema DJ; Radujkovic A; Finke J; Potter V; Killick SB; Legrand F; Solary E; Broom A; Garcia-Manero G; Rizzoli V; Hayden P; Patnaik MM; Onida F; Yakoub-Agha I; Itzykson R
Blood; 2022 Sep; 140(12):1408-1418. PubMed ID: 35667047
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.
Locatelli F; Nöllke P; Zecca M; Korthof E; Lanino E; Peters C; Pession A; Kabisch H; Uderzo C; Bonfim CS; Bader P; Dilloo D; Stary J; Fischer A; Révész T; Führer M; Hasle H; Trebo M; van den Heuvel-Eibrink MM; Fenu S; Strahm B; Giorgiani G; Bonora MR; Duffner U; Niemeyer CM; ;
Blood; 2005 Jan; 105(1):410-9. PubMed ID: 15353481
[TBL] [Abstract][Full Text] [Related]
23. Graft-versus-leukemia is sufficient to induce remission in juvenile myelomonocytic leukemia.
Orchard PJ; Miller JS; McGlennen R; Davies SM; Ramsay NK
Bone Marrow Transplant; 1998 Jul; 22(2):201-3. PubMed ID: 9707031
[TBL] [Abstract][Full Text] [Related]
24. Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria.
Bergstraesser E; Hasle H; Rogge T; Fischer A; Zimmermann M; Noellke P; Niemeyer CM
Pediatr Blood Cancer; 2007 Oct; 49(5):629-33. PubMed ID: 16991133
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia.
Elliott MA; Tefferi A; Hogan WJ; Letendre L; Gastineau DA; Ansell SM; Dispenzieri A; Gertz MA; Hayman SR; Inwards DJ; Lacy MQ; Micallef IN; Porrata LF; Litzow MR
Bone Marrow Transplant; 2006 Jun; 37(11):1003-8. PubMed ID: 16604096
[TBL] [Abstract][Full Text] [Related]
26. Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.
Yoshimi A; Mohamed M; Bierings M; Urban C; Korthof E; Zecca M; Sykora KW; Duffner U; Trebo M; Matthes-Martin S; Sedlacek P; Klingebiel T; Lang P; Führer M; Claviez A; Wössmann W; Pession A; Arvidson J; O'Marcaigh AS; van den Heuvel-Eibrink MM; Starý J; Hasle H; Nöllke P; Locatelli F; Niemeyer CM
Leukemia; 2007 Mar; 21(3):556-60. PubMed ID: 17268527
[No Abstract] [Full Text] [Related]
27. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities.
Eissa H; Gooley TA; Sorror ML; Nguyen F; Scott BL; Doney K; Loeb KR; Martin PJ; Pagel JM; Radich JP; Sandmaier BM; Warren EH; Storb R; Appelbaum FR; Deeg HJ
Biol Blood Marrow Transplant; 2011 Jun; 17(6):908-15. PubMed ID: 20932924
[TBL] [Abstract][Full Text] [Related]
29. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
30. A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
Yabe M; Sako M; Yabe H; Osugi Y; Kurosawa H; Nara T; Tokuyama M; Adachi S; Kobayashi C; Yanagimachi M; Ohtsuka Y; Nakazawa Y; Ogawa C; Manabe A; Kojima S; Nakahata T;
Pediatr Transplant; 2008 Dec; 12(8):862-7. PubMed ID: 18397212
[TBL] [Abstract][Full Text] [Related]
31. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
32. Transplantation of related and unrelated umbilical cord blood stem cells in Austria. Austrian Working Party for Stem Cell Transplantation. Austrian Society of Hematology and Oncology.
Schwinger W; Urban C; Lackner H; Kerbl R; Sovinz P; Gardner H; Peters C; Niederwieser D; Fink FM; Kögler G
Wien Klin Wochenschr; 1999 May; 111(9):348-53. PubMed ID: 10407995
[TBL] [Abstract][Full Text] [Related]
33. Development of T-cell acute lymphoblastic leukemia in a patient in very long lasting complete remission of juvenile myelomonocytic leukemia.
Maschan AA; Khachatrian LA; Solopova GG; Ossipova EY; Baidun LV; Dmitrieva SV; Maschan MA; Resnik IB
J Pediatr Hematol Oncol; 2011 Jan; 33(1):e32-4. PubMed ID: 21102353
[TBL] [Abstract][Full Text] [Related]
34. Second allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia: case report and literature review.
Chang YH; Jou ST; Lin DT; Lu MY; Lin KH
J Pediatr Hematol Oncol; 2004 Mar; 26(3):190-3. PubMed ID: 15125612
[TBL] [Abstract][Full Text] [Related]
35. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
36. Haemopoietic cell transplantation in children with juvenile myelomonocytic leukaemia.
MacMillan ML; Davies SM; Orchard PJ; Ramsay NK; Wagner JE
Br J Haematol; 1998 Nov; 103(2):552-8. PubMed ID: 9827934
[TBL] [Abstract][Full Text] [Related]
37. [Second allogeneic transplant for leukemia relapsed after first allogeneic transplantation].
Yang DL; Han MZ; Feng SZ; Wang M; Zou DH; Wei JL; Yan ZS; Zhou SY; Liu QG; Jiang EL; Huang Y; Wang HH; Zhou Z; Zhai WJ; Yan WW; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):285-9. PubMed ID: 15182537
[TBL] [Abstract][Full Text] [Related]
38. [A comparison of the therapeutic effects between related donor and unrelated donor allogeneic hematopoietic stem cell transplantation in treatment of leukemia].
Yang K; Liu QF; Fan ZP; Sun J; Xu D; Wei YQ; Zhang Y; Meng FY
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):135-9. PubMed ID: 17445441
[TBL] [Abstract][Full Text] [Related]
39. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
40. A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society.
Espérou H; Boiron JM; Cayuela JM; Blanchet O; Kuentz M; Jouet JP; Milpied N; Cahn JY; Faucher C; Bourhis JH; Michallet M; Tanguy ML; Vernant JP; Gabert J; Bordigoni P; Ifrah N; Baruchel A; Dombret H;
Bone Marrow Transplant; 2003 May; 31(10):909-18. PubMed ID: 12748668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
